N-DESMETHYLTAMOXIFEN, HYDROCHLORIDE
- CAS No.
- 31750-48-8
- Chemical Name:
- N-DESMETHYLTAMOXIFEN, HYDROCHLORIDE
- Synonyms
- ici55,548;desmethyltamoxifen;n-desmethyltamoxifen;Tamoxifen EP Impurity F;N-DESMETHYL TAMOXIFEN HCL;tamoxifen citrate impurity F;N-DEMETHYLTAMOXIFEN, HYDROCHLORIDE;N-DESMETHYLTAMOXIFEN, HYDROCHLORIDE;2-diphenyl-1-butenyl)phenoxy)-n-methyl-2-(p-((z)-ethylamin;2-diphenyl-1-butenyl)phenoxy)-n-methyl-2-(4-((z)-ethanamin
- CBNumber:
- CB2267847
- Molecular Formula:
- C25H27NO
- Molecular Weight:
- 357.49
- MDL Number:
- MFCD03423594
- MOL File:
- 31750-48-8.mol
Boiling point | 485.8±33.0 °C(Predicted) |
---|---|
Density | 1.047±0.06 g/cm3(Predicted) |
storage temp. | Store at -20°C |
solubility | DMSO: 72 mg/mL (201.40 mM);Ethanol: 36 mg/mL (100.70 mM) |
pka | 9.38±0.10(Predicted) |
Water Solubility | Water: Insoluble |
FDA UNII | OOJ759O35C |
SAFETY
Risk and Safety Statements
Symbol(GHS) | GHS08,GHS07 |
---|---|
Signal word | Danger |
Hazard statements | H350-H302-H372-H360 |
Precautionary statements | P264-P270-P301+P312-P330-P501-P260-P264-P270-P314-P501 |
N-DESMETHYLTAMOXIFEN, HYDROCHLORIDE price
Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|---|
Usbiological | D3220-90M | N-Desmethyltamoxifen, Hydrochloride | 31750-48-8 | 5mg | $460 | 2021-12-16 | Buy |
Medical Isotopes, Inc. | 34558 | N-Desmethyltamoxifen HCl | 31750-48-8 | 5mg | $1440 | 2021-12-16 | Buy |
Acrotein | DM-3492 | 2-[4-[(1Z)-1,2-Diphenyl-1-buten-1-yl]phenoxy]-N-methylethanamineHCl 97% | 31750-48-8 | 1g | $220 | 2021-12-16 | Buy |
N-DESMETHYLTAMOXIFEN, HYDROCHLORIDE Chemical Properties,Uses,Production
Definition
ChEBI: N-Desmethyltamoxifen is a stilbenoid.
Biological Activity
N-Desmethyltamoxifen is the main metabolite of Tamoxifen in the human body. N-Desmethyltamoxifen, a weaker antiestrogen, is a protein kinase C (PKC) inhibitor ten times stronger than Tamoxifen. It is also a potent regulator of ceramide metabolism in human AML cells, limiting ceramide glycosylation, hydrolysis and sphingosine phosphorylation.
in vitro
N-desmethyltamoxifen (20-500 ng/ml; 48 hours) has a profound inhibitory effect upon all seven glioma lines (T98G, U87, U138, U373, ALW, AUK, CAS cells).
It inhibits growth of MCF 7 human mammary carcinoma cells.
N-desmethyltamoxifen, resulting from the CYP3A4/5-mediated catalysis of tamoxifen, is the major primary quantitative metabolite of tamoxifen.
Cell Viability Assay
Cell Line: | MCF 7 human mammary carcinoma cells |
Concentration: | 1.5, 2.5, 5, 7.5, 10 μM | td>
Incubation Time: | 114 hours |
Result: | Inhibits growth of MCF 7 human mammary carcinoma cells |
target
PKC
| Estrogen Receptor
| < /table>
Supplier | Tel | Country | ProdList | Advantage | |
---|---|---|---|---|---|
TargetMol Chemicals Inc. | +1-781-999-5354 +1-00000000000 | marketing@targetmol.com | United States | 32161 | 58 |
Career Henan Chemica Co | +86-0371-86658258 +8613203830695 | laboratory@coreychem.com | China | 30236 | 58 |
Nextpeptide Inc | +86-0571-81612335 +8613336028439 | sales@nextpeptide.com | China | 19908 | 58 |
Wuhan Jingkang en Biomedical Technology Co., Ltd | +8613720134139 | orders@jknbiochem.com | China | 5221 | 58 |
QUALITY CONTROL SOLUTIONS LTD. | 0755-66853366; 13670046396 | ORDERS@QCSRM.COM | China | 24342 | 58 |
3B Pharmachem (Wuhan) International Co.,Ltd. | 821-50328103-801 18930552037 | 3bsc@sina.com | China | 15839 | 69 |
Daicel Chiral Technologies (China)CO.,LTD | 021-50460086-9 15921403865 | han_yajun@dctc.daicel.com | China | 6791 | 65 |
ChemStrong Scientific Co.,Ltd | 0755-0755-66853366 13670046396 | sales@chem-strong.com | China | 18105 | 56 |
Shanghai EFE Biological Technology Co., Ltd. | 021-65675885 18964387627 | info@efebio.com | China | 9806 | 58 |
Tianjin Kailiqi Biotechnology Co., Ltd. | 15076683720 | klq@cw-bio.com | China | 5944 | 55 |